E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/19/2006 in the Prospect News Biotech Daily.

SFBC upgraded to buy by Jefferies

SFBC International Inc. was upgraded by Jefferies & Co. analyst David Windley to a buy rating from hold with a $25 price target based on conversations with new management, competitors and some regulators. Jefferies is confident that risk issues are being addressed and that operational turbulence is waning. Shares of the Miami, Fla., pharmaceutical company were up $1.08, or 5.96%, at $19.20 on volume of 2,787,047 shares versus the three-month running average of 2,444,130 shares. (Nasdaq: SFCC)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.